Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01883414 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01883414 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 14 participants.
The verdict
NCT01883414, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Up to 25 subjects will be enrolled. Enrolled subjects will received on Ulthera® treatment on one half of their surgical scar. Follow up visits will occur at 30, 90 and 180 days after treatment. Study images will be obtained before treatment, immediately after treatment and at each follow-up visit.
Interventions
- DEVICE Ultherapy™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01883414
The ClinicalTrials.gov registry entry for NCT01883414 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultherapy™ is the first listed.
NCT01883414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01883414 about?
NCT01883414 is a clinical study titled "Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.". Up to 25 subjects will be enrolled. Enrolled subjects will received on Ulthera® treatment on one half of their surgical scar. Follow up visits will occur at 30, 90 and 180 days after treatment. Study images will be obtained before treatment, immediately after treatment and at each follow-up visit.
What is the current status of trial NCT01883414?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2013-06. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01883414?
The interventions under investigation include: Ultherapy™ (DEVICE).
Who is sponsoring clinical trial NCT01883414?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.